Navigation Links
Treatment to benefit African infants at risk of endemic fever
Date:4/22/2012

Thousands of pre-school children in Africa could benefit from access to treatment for an endemic disease, after tests showed infants to be at high risk of infection.

Researchers tested hundreds of children aged between one and five in countries in sub-Saharan Africa where snail fever also known as bilharzia or schistosomiasis is endemic. Currently, infants are not regularly tested for infection as they are perceived to be at low risk of exposure to the water-borne disease and not to suffer severely from its ill-effects.

Scientists showed that in fact, infection rates are high among pre-school children. This may be because they often accompany their mothers to rivers and wells. Symptoms of the disease which can include impaired memory and thought as well as damage to internal organs and stunted growth are not always obvious.

The study found that a common snail fever drug, known as praziquantel, which is regularly given to older children and adults, can safely cure the infection in infants. The treatment is cheap and effective, curing infection and stopping progress of disease in a single dose.

Researchers from the University of Edinburgh carried out studies in Zimbabwe and their results were combined with work by other teams in Mali, Sudan, Egypt, Niger and Uganda. In a recent World Health Organisation report, the teams recommended that infants be included in treatment programmes, and their work is informing public health policy.

According to the WHO, snail fever affects 230 million people each year, most of whom are African. Some 33.5 million people were treated for the disease in 2010. Children are especially vulnerable because they make frequent contact with infected water.

Dr Francisca Mutapi, of the University of Edinburgh's School of Biological Sciences, who took part in the study, said: "Snail fever is a widespread disease of major health consequence in young children. Our study shows that infants are especially vulnerable to infection and should be included in public health treatment programmes."


'/>"/>

Contact: Catriona Kelly
catriona.kelly@ed.ac.uk
44-131-651-4401
University of Edinburgh
Source:Eurekalert

Related biology news :

1. Drug interactions wont exclude HCV transplant or HIV co-infected patients from treatment
2. As deadly cat disease spreads nationally, MU veterinarian finds effective treatment
3. Promising developments in early diagnosis and treatment of mesothelioma
4. Antipsychotic drug may be helpful treatment for anorexia nervosa
5. New discovery may lead to effective prevention and treatment of graft-versus-host dsease
6. Researcher who identifed genetic cause and possible treatment for Marfan syndrome honored
7. Penn research points to new way of preserving fertility for boys undergoing cancer treatment
8. Minimally invasive treatment for ruptured aneurysm: Safe, reduces mortality
9. New discoveries about brain-hand connection sought to improve therapies, treatments, prosthetics
10. Marshall University study may lead to new treatments for prostate cancer
11. Step forward in research into new treatments for brain edema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... Solutions, a global clinical research organization (CRO), announces the launch of ... 4, 2017. Shadow is designed to assist medical writers and biometrics ... the European Medicines Agency (EMA) in meeting the requirements for de-identifying ... ... ...
(Date:6/30/2017)... , June 30, 2017 Today, American ... and supplier of face and eye tracking software, ... Product provider program. "Artificial intelligence ... way to monitor a driver,s attentiveness levels while ... being able to detect fatigue and prevent potential ...
(Date:5/16/2017)... , May 16, 2017  Veratad Technologies, LLC ( ... online age and identity verification solutions, announced today they ... Conference 2017, May 15 thru May 17, 2017, in ... and International Trade Center. Identity impacts ... and in today,s quickly evolving digital world, defining identity ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back ... 8th June 2018 in San Francisco, CA. The Summit brings together current and former ... CEOs, board directors and government officials from around the world to address key issues ...
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today ... designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) ... able to cross the cell membrane and bind intracellular STAT3 and inhibit its ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the ... for Excellence in Volunteer Experience from US2020. , US2020’s mission is to change ...
Breaking Biology Technology: